Detalhe da pesquisa
1.
First-site-metastasis pattern in patients with inoperable stage III NSCLC treated with concurrent chemoradiotherapy with or without immune check-point inhibition: a retrospective analysis.
Strahlenther Onkol
; 2023 Nov 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-37975883
2.
Metabolic patterns on [18F]FDG PET/CT in patients with unresectable stage III NSCLC undergoing chemoradiotherapy ± durvalumab maintenance treatment.
Eur J Nucl Med Mol Imaging
; 50(8): 2466-2476, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-36951991
3.
Pooled analysis on image-guided moderately hypofractionated thoracic irradiation in inoperable node-positive/recurrent patients with non-small cell lung cancer with poor prognostic factors and severely limited pulmonary function and reserve.
Cancer
; 128(12): 2358-2366, 2022 06 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-35417563
4.
Planning target volume as a predictor of disease progression in inoperable stage III non-small cell lung cancer patients treated with chemoradiotherapy and concurrent and/or sequential immune checkpoint inhibition.
Invest New Drugs
; 40(1): 163-171, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34351518
5.
Outcome after PSMA-PET/CT-based salvage radiotherapy for nodal recurrence after radical prostatectomy.
Eur J Nucl Med Mol Imaging
; 49(4): 1417-1428, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-34628521
6.
Differential role of residual metabolic tumor volume in inoperable stage III NSCLC after chemoradiotherapy ± immune checkpoint inhibition.
Eur J Nucl Med Mol Imaging
; 49(4): 1407-1416, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-34664091
7.
Primary radiation therapy in stage I/II indolent orbital lymphoma - a comprehensive retrospective recurrence and toxicity analysis.
Eur J Haematol
; 109(1): 21-30, 2022 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-35276022
8.
Real-world prospective analysis of treatment patterns in durvalumab maintenance after chemoradiotherapy in unresectable, locally advanced NSCLC patients.
Invest New Drugs
; 39(4): 1189-1196, 2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-33704621
9.
PET/CT imaging for evaluation of multimodal treatment efficacy and toxicity in advanced NSCLC-current state and future directions.
Eur J Nucl Med Mol Imaging
; 48(12): 3975-3989, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-33760957
10.
PSMA-positive nodal recurrence in prostate cancer : Salvage radiotherapy is superior to salvage lymph node dissection in retrospective analysis.
Strahlenther Onkol
; 196(7): 637-646, 2020 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-32211942
11.
External Validation of a Survival Score for Limited-Stage Small Cell Lung Cancer Patients Treated with Chemoradiotherapy.
Lung
; 198(1): 201-206, 2020 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-31897594
12.
Analysis of primary tumor metabolic volume during chemoradiotherapy in locally advanced non-small cell lung cancer.
Strahlenther Onkol
; 194(2): 107-115, 2018 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-29116336
13.
Correction to: Analysis of primary tumor metabolic volume during chemoradiotherapy in locally advanced non-small cell lung cancer.
Strahlenther Onkol
; 194(4): 363-364, 2018 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-29541791
14.
Predictive and prognostic value of tumor volume and its changes during radical radiotherapy of stage III non-small cell lung cancer : A systematic review.
Strahlenther Onkol
; 194(2): 79-90, 2018 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-29030654
15.
How much primary tumor metabolic volume reduction is required to improve outcome in stage III NSCLC after chemoradiotherapy? A single-centre experience.
Eur J Nucl Med Mol Imaging
; 45(12): 2103-2109, 2018 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-29876620
16.
Prognostic role of patient gender in limited-disease small-cell lung cancer treated with chemoradiotherapy.
Strahlenther Onkol
; 193(2): 150-155, 2017 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-27853828
17.
Evaluation of the role of remission status in a heterogeneous limited disease small-cell lung cancer patient cohort treated with definitive chemoradiotherapy.
BMC Cancer
; 16: 216, 2016 Mar 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-26975407
18.
Feasibility of hypofractionated radiotherapy in inoperable node-positive NSCLC patients with poor prognostic factors and limited pulmonary reserve: a prospective observational study.
Acta Oncol
; 60(8): 1074-1078, 2021 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-34155956
19.
Multimodal "synergistic" treatment based on tumour immunological contexture for advanced non-driver non-small cell lung cancer: A myth or reality?
Eur J Cancer Care (Engl)
; 29(5): e13291, 2020 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-32705732
20.
The role of online MR-guided multi-fraction stereotactic ablative radiotherapy in lung tumours.
Clin Transl Radiat Oncol
; 45: 100736, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38433949